TIM DAVID OURY
Medical Practice in Wexford, PA
License number
Pennsylvania MD065432L
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
Wexford, PA 15090
Personal information
See more information about TIM DAVID OURY at radaris.comName
Address
Phone
2434 Dogwood Dr, Wexford, PA 15090
2434 Dogwood Dr, Wexford, PA 15090
Professional information
Mmp Activation Peptide Detection In Biological Samples
US Patent:
8568996, Oct 29, 2013
Filed:
Oct 2, 2009
Appl. No.:
13/121142
Inventors:
Jan Johannes Enghild - Aarhus, DK
Naftali Kaminski - Pittsburgh PA, US
Tim D. Oury - Wexford PA, US
Laura Voeghtly - Tarentum PA, US
Naftali Kaminski - Pittsburgh PA, US
Tim D. Oury - Wexford PA, US
Laura Voeghtly - Tarentum PA, US
Assignee:
University of Pittsburgh—Of the Commonwealth System of Higher Education - Pittsburgh PA
International Classification:
G01N 31/00, G01N 33/53
US Classification:
435 721, 435 71, 436501, 436518, 422430, 530300, 530350
Abstract:
A method is provided along with related reagent kits for aiding the diagnosis of IPF or other interstitial lung diseases, as well as for potential monitoring of disease progression or therapeutic response to treatment.
Method Of Detecting Prostate Specific Antigen
US Patent:
6300088, Oct 9, 2001
Filed:
Nov 18, 1998
Appl. No.:
9/193263
Inventors:
Jan J. Enghild - Durham NC
Tim D. Oury - Wexford PA
Ida B. Thogersen - Durham NC
Zuzana Valnickova - Durham NC
Philip J. Walther - Durham NC
Tim D. Oury - Wexford PA
Ida B. Thogersen - Durham NC
Zuzana Valnickova - Durham NC
Philip J. Walther - Durham NC
Assignee:
Duke University - Durham NC
International Classification:
G01N 33574, A61K 3804, C07K 1600, C07K 1700, C07K 500
US Classification:
435 723
Abstract:
Dectection of secreted Prostate Specific Antigen (PSA) by detecting the presence of an N-terminal activation peptide of PSA in a biological sample is described. The method may be used in screening for or diagnosing disease states associated with increased levels of secreted prostate specific antigen.
Biologic Scaffold For Prevention Of Pulmonary Fibrosis
US Patent:
2011026, Oct 27, 2011
Filed:
Dec 4, 2009
Appl. No.:
13/132708
Inventors:
Thomas Gilbert - Pittsburgh PA, US
Michelle Manni - Sewickley PA, US
Tim D. Oury - Wexford PA, US
Michelle Manni - Sewickley PA, US
Tim D. Oury - Wexford PA, US
Assignee:
University of Pittsburgh-Of the Commonwealth System of Higher Education - Pittsburgh PA
International Classification:
A61K 9/12, A61P 11/00, A61K 35/22, A61K 9/00, A61K 35/12
US Classification:
424400, 424 43, 424520, 424558
Abstract:
Provided herein are methods of preventing, lessening or treating pulmonary fibrosis in a subject. The methods comprise delivering an amount of a powdered extracellular matrix (ECM)-derived material to the respiratory system of the subject effective to prevent, lessen or treat pulmonary fibrosis in a subject. Also provided is an apparatus for delivering the powdered ECM-derived material to a subject.